The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 10.50
Ask: 11.50
Change: -0.25 (-2.22%)
Spread: 1.00 (9.524%)
Open: 11.25
High: 11.05
Low: 10.50
Prev. Close: 11.25
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Salarius Completes Oversubscribed Crowdfund

4 Jan 2022 07:00

RNS Number : 2491X
Tekcapital plc
04 January 2022
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

4 January 2022

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

 

Portfolio Company Update: Salarius, Ltd. ("Salarius")

MicroSalt Inc. completes oversubscribed Crowdfund

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology that can improve people's lives, is pleased to announce that Salarius' U.S. subsidiary MicroSalt Inc (MicroSalt) has completed an oversubscribed Reg CF Crowdfund, having achieved its goal of $750,000.

 

About Salarius Ltd. and MicroSalt, Inc.

Salarius, is the developer and manufacturer of a proprietary low-sodium salt called MicroSalt®. We are passionate about improving people's lives by providing the best low-sodium salt. MicroSalt, Inc., Salarius' U.S. operating subsidiary, aims to revolutionize the food industry with its patented better-for-you salt, that delivers the full-flavour experience of salt with roughly half the sodium. MicroSalt® is all-natural, non-GMO, and Kosher. Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides improved flavor consistency. MicroSalt® and SaltMe® are registered trademarks of MicroSalt Inc. To learn more about MicroSalt please visit https://www.microsaltinc.com/. To learn more about SaltMe! snacks please visit https://saltme.com/.

 

Tekcapital owns 97.2% of the share capital of Salarius Ltd. and approximately 76% of the share capital of MicroSalt Inc., its U.S. subsidiary. The current post-money valuation of MicroSalt Inc. is ~U.S. $5.75m.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel  Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

 

Flagstaff Strategic and Investor Communications +44 (0)207 129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Salarius that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Salarius' and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Salarius or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Salarius nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUUPUWCGUPPGMW
Date   Source Headline
5th Aug 20193:21 pmRNSHolding(s) in Company - Replacement
2nd Aug 20194:15 pmRNSHolding(s) in Company
1st Aug 201911:35 amRNSHolding(s) in Company
1st Aug 201911:34 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSInvestor Conference Call
22nd Jul 20197:00 amRNSExpansion of Tekcapital services in Mexico
16th Jul 20197:00 amRNSNotice of Investor Conference Call
11th Jul 20197:00 amRNSPlacing to raise £0.75 million
27th Jun 20197:00 amRNSGuident Acquires Additional IP
26th Jun 20197:00 amRNSBelluscura likely to receive FDA clearance in 2019
25th Jun 20197:00 amRNSGuident Acquires Additional IP
24th Jun 20197:00 amRNSSalarius Secures New Order for MicroSalt®
13th Jun 20197:00 amRNSSalarius Secures & Delivers Follow-on Order
14th May 20197:00 amRNSLucyd Launches Loud 2.0 Eyewear Line
3rd May 20197:00 amRNSFlorida Legislature Approves Autonomous Vehicles
29th Apr 20197:00 amRNSGuident Files Additional Patent
24th Apr 20197:00 amRNSPortfolio company, Belluscura plc, raises £500,730
23rd Apr 201911:05 amRNSSecond Price Monitoring Extn
23rd Apr 201911:00 amRNSPrice Monitoring Extension
23rd Apr 20197:00 amRNSSalarius secures first commercial order
5th Apr 20193:12 pmRNSResult of AGM
2nd Apr 20197:00 amRNSStrategic Alliance Agreement with Emprende UP
1st Apr 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSAttendance at UK Investor Show
14th Mar 20197:00 amRNSInvestor conference call
14th Mar 20197:00 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20195:26 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSUpdate of Research Coverage
26th Feb 20197:00 amRNSNotice of Investor Conference Call
25th Feb 20197:00 amRNSFull Year 2018 Preliminary Results
21st Feb 20197:00 amRNSLucyd Provides Market Update
21st Feb 20197:00 amRNSNotice of Preliminary Results Announcement
19th Feb 20198:52 amRNSBelluscura Files Additional Patent
15th Feb 20193:26 pmRNSHolding(s) in Company
30th Jan 20199:23 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSGuident Ltd Appoints Director
17th Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSUniversity IP webinar
6th Dec 20187:00 amRNSGuident Ltd Appoints Director
3rd Dec 20187:00 amRNSLucyd Signs R Sherman as Chief Brand Officer
26th Nov 20187:00 amRNSMello London
14th Nov 20187:00 amRNSLucyd Launches Affiliate and Reseller Program
8th Nov 201811:34 amRNSHolding(s) in Company
19th Oct 20181:52 pmRNSHolding(s) in Company
18th Oct 20185:25 pmRNSHolding(s) in Company
16th Oct 20185:02 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSPortfolio Company Update
9th Oct 20187:00 amRNSExecutive Appointment
5th Oct 20187:00 amRNSScience Advisor Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.